myeloid neoplasms

Evaluation of Morphology in Myeloid Neoplasms: ICC Series Part Three

by
Evaluation of Morphology in Myeloid Neoplasms: ICC Series Part Three

MorphologyMorphologyPeripheral blood specimenPeripheral blood specimen A well-prepared and well-stained peripheral blood smear should be examined and correlated with the patient’s blood counts. Cytology of leukocytes, red blood cells, and platelets should be evaluated. A manual 200-cell leukocyte differential count (or counting of all available cells in markedly leukopenic cases) should be performed as part of … Read more

Chapter 6 of ICC: Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions (M/LN-eo-TK)

by
Chapter 6 of ICC: Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions (M/LN-eo-TK)

In the 2008 (4th edition) World Health Organization (WHO) classification, this disease category was first established, originally named myeloid/lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1 genes. In the revised 4th edition WHO classification, PCM1::JAK2 and its genetic variants were introduced as provisional entity subtypes within this category. In the current classification, … Read more